Return on Equity (ROE)
since 2005
Calculation
Eli Lilly & Co., ROE, long-term trends, calculation
| ROE | = | 100 | × | Net income (loss)1 | ÷ | Total Eli Lilly and Company shareholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 319.09% | = | 100 | × | 8,318,400 | ÷ | 2,606,900 |
| Dec 31, 2018 | 32.88% | = | 100 | × | 3,232,000 | ÷ | 9,828,700 |
| Dec 31, 2017 | -1.76% | = | 100 | × | (204,100) | ÷ | 11,592,200 |
| Dec 31, 2016 | 19.54% | = | 100 | × | 2,737,600 | ÷ | 14,007,700 |
| Dec 31, 2015 | 16.53% | = | 100 | × | 2,408,400 | ÷ | 14,571,300 |
| Dec 31, 2014 | 15.55% | = | 100 | × | 2,390,500 | ÷ | 15,373,200 |
| Dec 31, 2013 | 26.57% | = | 100 | × | 4,684,800 | ÷ | 17,631,400 |
| Dec 31, 2012 | 27.69% | = | 100 | × | 4,088,600 | ÷ | 14,765,200 |
| Dec 31, 2011 | 32.11% | = | 100 | × | 4,347,700 | ÷ | 13,541,700 |
| Dec 31, 2010 | 40.82% | = | 100 | × | 5,069,500 | ÷ | 12,420,300 |
| Dec 31, 2009 | 45.45% | = | 100 | × | 4,328,800 | ÷ | 9,523,700 |
| Dec 31, 2008 | -30.76% | = | 100 | × | (2,071,900) | ÷ | 6,735,300 |
| Dec 31, 2007 | 21.61% | = | 100 | × | 2,953,000 | ÷ | 13,664,400 |
| Dec 31, 2006 | 24.25% | = | 100 | × | 2,662,700 | ÷ | 10,980,700 |
| Dec 31, 2005 | 18.34% | = | 100 | × | 1,979,600 | ÷ | 10,791,900 |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
1 US$ in thousands
Comparison to Competitors
Eli Lilly & Co., ROE, long-term trends, comparison to competitors
| Eli Lilly & Co. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 319.09% | 11.86% | — | 81.07% | 44.13% | 6.66% | 23.91% | 21.72% | 25.42% | 37.99% | 25.77% | 19.08% | 19.34% | 55.39% |
| Dec 31, 2018 | 32.88% | 7.76% | — | 67.15% | 33.98% | 35.07% | 25.51% | 21.98% | 25.60% | 23.30% | 17.59% | 27.91% | 47.28% | 65.35% |
| Dec 31, 2017 | -1.76% | 1.54% | 104.16% | 7.84% | 20.13% | 8.58% | 22.64% | 26.41% | 2.16% | 6.97% | 29.47% | 19.51% | 12.99% | 48.81% |
| Dec 31, 2016 | 19.54% | 6.82% | 128.41% | 25.85% | 30.50% | 27.55% | 71.48% | 21.06% | 23.49% | 9.78% | 12.12% | 20.13% | -9.69% | 55.21% |
| Dec 31, 2015 | 16.53% | 20.85% | 130.39% | 24.71% | 37.84% | 10.97% | 97.70% | 24.97% | 21.66% | 9.94% | 10.75% | 17.40% | -59.19% | 31.74% |
| Dec 31, 2014 | 15.55% | 10.61% | 101.84% | 20.01% | 27.15% | 13.49% | 78.45% | 24.16% | 23.40% | 24.50% | 12.81% | 13.69% | -68.70% | 44.47% |
| Dec 31, 2013 | 26.57% | 10.23% | 91.90% | 23.00% | 21.60% | 16.91% | 27.05% | 8.17% | 18.68% | 8.85% | 28.83% | 21.74% | -32.81% | 53.62% |
| Dec 31, 2012 | 27.69% | 22.32% | 156.85% | 22.80% | 19.82% | 14.39% | 27.84% | 11.47% | 16.74% | 11.63% | 17.93% | 60.24% | -10.71% | 10.83% |
| Dec 31, 2011 | 32.11% | 19.35% | — | 19.35% | 19.21% | 23.25% | 41.60% | 8.06% | 16.94% | 11.50% | 12.18% | -45.65% | 3.76% | — |
| Dec 31, 2010 | 40.82% | 20.66% | — | 19.32% | 18.63% | 19.74% | 49.48% | 10.43% | 23.57% | 1.58% | 9.40% | -19.79% | -149.74% | — |
| Dec 31, 2009 | 45.45% | 25.14% | — | 20.32% | 15.59% | 71.49% | 41.40% | 8.36% | 24.25% | 21.85% | 9.59% | -17.10% | -58.57% | — |
| Dec 31, 2008 | -30.76% | 27.92% | — | 20.58% | 13.49% | 42.86% | 48.43% | 5.95% | 30.46% | 41.63% | 14.08% | -19.75% | -192.51% | — |
| Dec 31, 2007 | 21.61% | 20.28% | — | 17.72% | 11.53% | 20.50% | 46.69% | -67.62% | 24.41% | 18.01% | 12.53% | -22.94% | -144.23% | — |
| Dec 31, 2006 | 24.25% | 12.22% | — | 15.56% | 3.04% | 15.86% | -65.54% | 16.16% | 28.11% | 25.25% | 27.10% | -47.24% | -40.89% | — |
| Dec 31, 2005 | 18.34% | 23.39% | — | 17.96% | 2.33% | 26.77% | 26.88% | -28.79% | 27.49% | 25.85% | 12.32% | -83.72% | -85.05% | — |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Eli Lilly & Co., ROE, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Eli Lilly & Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 319.09% | 30.26% |
| Dec 31, 2018 | 32.88% | 28.24% |
| Dec 31, 2017 | -1.76% | 14.74% |
| Dec 31, 2016 | 19.54% | 23.42% |
| Dec 31, 2015 | 16.53% | 23.43% |
| Dec 31, 2014 | 15.55% | 22.07% |
| Dec 31, 2013 | 26.57% | 20.88% |
| Dec 31, 2012 | 27.69% | 19.44% |
| Dec 31, 2011 | 32.11% | 16.42% |
| Dec 31, 2010 | 40.82% | 15.01% |
| Dec 31, 2009 | 45.45% | 21.81% |
| Dec 31, 2008 | -30.76% | 23.20% |
| Dec 31, 2007 | 21.61% | 17.99% |
| Dec 31, 2006 | 24.25% | 22.12% |
| Dec 31, 2005 | 18.34% | 18.98% |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
Comparison to Industry (Health Care)
Eli Lilly & Co., ROE, long-term trends, comparison to industry (health care)
| Eli Lilly & Co. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 319.09% | 23.89% |
| Dec 31, 2018 | 32.88% | 21.64% |
| Dec 31, 2017 | -1.76% | 13.74% |
| Dec 31, 2016 | 19.54% | 19.15% |
| Dec 31, 2015 | 16.53% | 18.87% |
| Dec 31, 2014 | 15.55% | 19.51% |
| Dec 31, 2013 | 26.57% | 19.03% |
| Dec 31, 2012 | 27.69% | 17.28% |
| Dec 31, 2011 | 32.11% | 16.02% |
| Dec 31, 2010 | 40.82% | 14.53% |
| Dec 31, 2009 | 45.45% | 19.17% |
| Dec 31, 2008 | -30.76% | 19.09% |
| Dec 31, 2007 | 21.61% | 16.79% |
| Dec 31, 2006 | 24.25% | 18.18% |
| Dec 31, 2005 | 18.34% | 18.69% |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).